Investors in Health Care

Exceptional Ventures, we are a London-based venture capital firm dedicated to investing in high-impact startups that contribute to improving the world we live in. Our mission is clear: we aim to help people live healthier, happier, and longer lives while promoting a sustainable planetary ecosystem. Through our debut fund, EV Fund 1, which targets £20 million in size, we are actively building a portfolio of 40 early-stage startups over the next three years. Our focus areas include HealthTech, FoodTech, and Financial Health, primarily within the UK/EU region while opportunistically exploring opportunities globally. Our founders, Matt Cooper and Paolo Pio, bring a wealth of experience to Exceptional Ventures. Matt's background includes co-founding Capital One Bank in the US, Tandem Bank in the UK, and chairing Octopus Group for over two decades. Paolo, formerly a Silicon Valley Software Engineer and Tech Executive, transitioned into venture capital as MD Europe at Joyance Partners, a prominent US HealthTech VC fund. With a combined portfolio of over 200 invested startups, we leverage our deep industry knowledge and extensive network to support entrepreneurs and drive positive societal impact through strategic investments.

Leafy Tunnel is a Venture Capital firm dedicated to investing in alternative medicine, focusing on the transformative potential of medicinal cannabis and psychedelics. Through direct investments, we aim to foster the growth of pioneering companies leading research, development, and commercialization in these sectors. In controlled therapeutic settings, these modalities offer promise in unraveling the mysteries of the mind, revealing pathways to self-discovery and emotional healing. Alternative medicine, particularly in psychedelic and cannabis therapies, challenges traditional healing approaches, merging ancient wisdom with modern science to explore the limitless potential of human consciousness. This convergence forms a new paradigm where art, music, and culture blend with therapeutic practices, enhancing self-exploration and emotional liberation. At Leafy Tunnel, we leverage our extensive network, expertise, and resources to collaborate with entrepreneurs and startups that share our vision for the future of alternative medicine. Our investment approach emphasizes rigorous analysis, honest feedback, and a commitment to ethical and sustainable practices.

LifeArc is an independent life science medical research charity dedicated to improving positive patient outcomes globally. As a pioneering organization, LifeArc focuses on translating cutting-edge biomedical research into tangible benefits for patients and society. Their mission spans across the entire medical innovation pipeline, from early-stage discovery to development and commercialization. LifeArc collaborates with academic institutions, research organizations, and industry partners to accelerate the translation of scientific discoveries into new treatments and therapies. Through strategic funding, expertise, and partnerships, LifeArc supports innovative projects that address unmet medical needs and advance medical science. Committed to making a significant impact on healthcare, LifeArc plays a crucial role in driving innovation, fostering collaboration, and ultimately, improving patient lives worldwide.

ODBA, we hold a firm conviction that founders with hands-on experience in launching, managing, and expanding businesses possess the keenest insight for investment. Our approach hinges on the understanding that the success of a venture is deeply intertwined with the caliber of its team. For us, a team's excellence reflects their collective passion, vision, dedication, and communication skills. People are at the heart of everything we do. We do not just invest in ventures, products, or ideas; we invest in the individuals who build them. As founders ourselves, we are committed to investing in people who resonate with our entrepreneurial spirit, wherever and however we find them.

At Verb Ventures, we are dedicated to identifying and empowering ambitious entrepreneurs with transformative ideas. Our focus lies in nurturing late seed and Series A stage companies, guiding them to become industry leaders. With our team of seasoned professionals, we leverage our global network, deep sector expertise, and entrepreneurial spirit to provide specialized support to startups poised to reshape marketplaces and B2B platforms.

Nova Growth Capital operates with a unique deal flow strategy sourced exclusively from its Cofoundery, a venture builder. This approach has resulted in impressive portfolio growth, averaging 36.5% year-over-year for the past 11 years. The firm specializes in identifying and supporting high-potential businesses emerging from its venture builder, providing strategic capital and operational expertise to accelerate their growth trajectories. Nova Growth Capital's focus on nurturing ventures through their critical early stages underscores its commitment to driving sustained growth and fostering innovation within its portfolio companies.

Start Codon focuses on translating disruptive research into successful startups, emphasizing a unique approach influenced by Cambridge's innovation ecosystem. The firm identifies promising technologies and research with commercial potential, providing seed funding, mentoring, and access to networks. Start Codon aims to accelerate the development of early-stage biotech and healthcare startups, contributing to breakthrough innovations in these fields. Through its tailored support and strategic guidance, Start Codon plays a crucial role in bridging the gap between scientific discovery and market-ready solutions.

Earlymarket is a London-based investment fund specializing in providing seed capital to companies within the technology industry. Focused on supporting early-stage ventures, Earlymarket plays a crucial role in nurturing innovation and entrepreneurship. They aim to empower promising startups by providing not just financial support but also strategic guidance and operational expertise. Earlymarket is committed to identifying and backing visionary founders with transformative ideas, helping them scale and succeed in competitive markets. For more information about Earlymarket and their investment approach, please visit earlymarket.com.

Earlymarket is a London-based investment fund specializing in providing seed capital to companies within the technology industry. Focused on supporting early-stage ventures, Earlymarket plays a crucial role in nurturing innovation and entrepreneurship. They aim to empower promising startups by providing not just financial support but also strategic guidance and operational expertise. Earlymarket is committed to identifying and backing visionary founders with transformative ideas, helping them scale and succeed in competitive markets. For more information about Earlymarket and their investment approach, please visit earlymarket.com.

AA Sons is the family office of Alain Afflelou and Sons, dedicated to managing their wealth and investments. As a family office, AA Sons focuses on a range of investment activities, including private equity, venture capital, real estate, and other asset classes. With a strategic approach tailored to long-term wealth preservation and growth, AA Sons leverages its deep industry knowledge and extensive network to identify and capitalize on investment opportunities globally. The family office plays a pivotal role in overseeing the Afflelou family's financial affairs and supporting strategic initiatives that align with their investment goals and values.

Playfair Capital is a venture capital fund that takes a contrarian approach to pre-seed technology investing. As a generalist VC, Playfair Capital seeks out early-stage startups across various technology sectors. The firm emphasizes backing visionary founders with innovative ideas and disruptive business models. Playfair Capital's investment philosophy centers on supporting startups in their formative stages, providing not only capital but also strategic guidance and operational support to help them achieve rapid growth and market success. For entrepreneurs seeking early-stage investment, Playfair Capital offers a platform to explore funding opportunities.

NextGen Ventures is a venture capital firm based in the Netherlands, specializing in early-stage investments in innovative technology startups. Founded with a focus on supporting ambitious entrepreneurs, NextGen Ventures seeks to back companies with the potential to disrupt their industries and achieve substantial growth. The firm's investment strategy centers around sectors such as software, fintech, healthtech, artificial intelligence, and other emerging technologies. NextGen Ventures provides seed and early-stage funding to startups, aiming to help them scale their businesses and bring innovative solutions to market. Beyond financial support, NextGen Ventures offers strategic guidance and operational expertise to its portfolio companies. This includes assistance with business development, market expansion, and accessing additional rounds of funding. The firm also leverages its network of industry connections and partners to create opportunities for growth and collaboration. NextGen Ventures is known for its hands-on approach and commitment to partnering with visionary founders. They aim to build long-term relationships and support startups through various stages of growth, from initial concept development to scaling into successful enterprises.